CD93通过触发PI3K/AKT通路,加剧细胞增殖,血管新生和骨髓瘤中的免疫逃逸
Yan Zhang1, Yongheng Liu1, Yulin Ma1
1Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, PR China.
概括
CD93通过PI3K/AKT通路增强细胞增殖,血管生成和免疫逃生来促进骨髓瘤的进展. 抑制CD93可能为骨髓瘤治疗提供治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 骨髓瘤是年轻人患有复杂遗传变异的常见骨癌.
- CD93与促进各种癌症的发展有关.
研究的目的:
- 研究CD93在骨髓瘤进展中的作用和调控途径.
- 探索CD93作为骨髓瘤的潜在治疗点.
主要方法:
- 使用GEO数据库,mRNA和蛋白质分析分析骨髓瘤组织和细胞系中CD93表达的分析.
- 在体外实验中评估CD93抑制对细胞增殖,血管生成和免疫逃逸的影响.
- 在体内研究评估CD93敲击后瘤生长.
- 调查PI3K/AKT通路的参与.
主要成果:
- 在骨髓瘤组织和细胞系中,CD93表达升高.
- 抑制CD93抑制了骨髓瘤细胞的增殖和血管生成.
- 抑制CD93降低了骨髓瘤中的免疫逃逸.
- CD93激活PI3K/AKT通路,促进骨髓瘤的进展.
- 在体内抑制CD93衰弱瘤生长.
结论:
- CD93通过促进PI3K/AKT通路的增殖,血管新生和免疫逃逸来加剧骨髓瘤的进展.
- 向CD93为骨髓瘤治疗提供了潜在的治疗途径.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


